Seeking Alpha
Seeking Alpha Portfolio App for iPad
Finance
(1)
Market Currents

Ligand Pharmaceuticals (LGND) Q4 EPS of $0.27 beats by $0.06. Revenue of $13.6M beats by $0.3M. (PR)

  • Wednesday, February 13, 6:56 PM ET
    Ligand Pharmaceuticals (LGND) Q4 EPS of $0.27 beats by $0.06. Revenue of $13.6M beats by $0.3M. (PR)
LATEST|
TODAY SO FAR|
YESTERDAY
Other date
DJIA (DIA) S&P 500 (SPY)
Latest Earnings Articles
More Latest Articles »